Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


INTEGRA LIFESCI   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Revenue1,371.871,517.561,472.441,188.24992.08882.73796.72696.83830.87780.08
Product sales--------------------
Other revenue--------------------
Total Revenues1,371.871,517.561,472.441,188.24992.08882.73796.72696.83830.87780.08
Cost of product revenues520.83564.68571.50435.51349.09326.54302.95279.55314.43299.15
Goodwill impairment charge----------------0.000.00
Amortization--------------------
Intangible asset amortization27.7627.0321.1620.3713.869.956.817.1018.5416.43
Research and development77.3879.5778.0463.4658.1650.9043.5642.6251.0151.45
In-process research and development0.0064.920.000.00------------
General and Administrative--------------------
Selling, general and administrative594.53687.60690.75624.10455.63415.76375.55332.19373.11358.13
Selling and marketing--------------------
Operating Income (Loss)151.3793.76111.0044.80115.3479.5967.8635.3773.7854.91
Interest expense71.5853.9664.6835.0225.8023.5321.9719.7322.2427.64
Interest income9.3010.782.800.260.020.030.174.931.210.47
Other income (expense), net4.439.528.291.350.854.59(0.49)(1.80)(0.72)0.76
Gain on dispositions of product lines--------------------
Income (loss) before income taxes93.5260.1057.4011.3990.4160.6745.5718.7952.0328.49
United States operations----------37.4521.356.51--1.51
Foreign operations----------23.2224.2212.27--26.99
Current-State--------2.502.302.120.401.37(1.53)
Current- Foreign--------6.115.213.670.634.301.81
Deferred- Foreign--------(1.32)(1.24)(2.02)2.20(3.01)(2.16)
Deferred:Federal(5.08)(10.89)(7.20)(66.47)(3.40)1.28(5.52)(2.41)4.051.08
Deferred:State(1.76)(0.67)(3.05)(0.76)(1.75)(0.39)0.70(1.14)0.502.24
Provision for income taxes(40.37)9.90(3.40)(53.36)15.8453.829.27(3.24)10.830.51
Current-Federal6.1814.60(3.88)6.6413.7046.6710.33(2.93)3.61(0.93)
Income(Loss) from continuing operations----------6.8536.3022.03----
Income (Loss) from discontinued operations----------(10.37)(2.29)(43.09)----
Net income (loss) before accounting change--------------------
Cumulative effect of accounting change--------------------
Net Income (Loss) Available to Common Shareholders133.8950.2060.8064.7474.56(3.52)34.00(21.07)41.2027.99
Basic net income (loss) per share before extraordinary item and cumulative effec--------------------
continuing operations ( basic)----------0.100.560.39----
Income (loss) from discontinued operations ( basic)----------(0.15)(0.04)(0.76)----
Basic net income per share1.580.590.730.841.00(0.05)0.52(0.37)0.730.49
Continuing operations (Diluted)----------0.100.550.38----
Diluted net income (loss) per share before extraordinary item and cumulative eff--------------------
Income (loss) from discontinued operations (Diluted)----------(0.15)(0.03)(0.75)----
Diluted net income per share1.570.580.720.820.94(0.05)0.52(0.37)0.720.48
Weighted Average Shares Outstanding (Basic)84.6585.6482.8676.9074.3968.9964.8656.8356.4657.90
Weighted Average Shares Outstanding (Diluted)85.2386.4984.0079.1279.1971.3565.9257.6057.0358.99